JNS001

DRUG2 trials

Sponsors

Janssen Pharmaceutical K.K.

Conditions

Attention-Deficit / Hyperactivity DisorderAttention-Deficit Hyperactivity Disorder

Phase 3

An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder

CompletedNCT01323192

Janssen Pharmaceutical K.K.Attention-Deficit Hyperactivity Disorder

Start: 2011-03-31End: 2012-04-30Updated: 2013-09-06

A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder

CompletedNCT01357993

Janssen Pharmaceutical K.K.Attention-Deficit / Hyperactivity Disorder

Start: 2011-05-31End: 2013-03-31Updated: 2014-03-28